Discontinuing antimicrobial therapies after a patient is no longer symptomatic does not increase the likelihood that resistance will develop.

A. True
B. False



Answer :

Final answer:

Prematurely discontinuing antimicrobial therapies can lead to drug resistance, superinfections, and challenges in controlling pathogens.


Explanation:

False: Discontinuing antimicrobial therapies after a patient is no longer symptomatic increases the likelihood that resistance will develop. When patients stop taking antimicrobial drugs prematurely, it can lead to incomplete elimination of the target organisms, promoting the selection of drug-resistant variants in the target population and the patient's microbiota.

Nonadherence to antimicrobial treatment plans, especially for long courses like tuberculosis, contributes significantly to antibiotic resistance, making it harder to control pathogens. Using broad-spectrum antimicrobials can also increase the risk of superinfections, further complicating treatment.

Factors like patients feeling better before completing the full treatment course and lack of awareness about the consequences of premature discontinuation can result in negative impacts such as the emergence of multidrug-resistant strains and difficulties in managing infections.


Learn more about Antimicrobial drug resistance and treatment adherence here:

https://brainly.com/question/31627382